Market New Research Head and Neck Cancer Treatment Market Trends 2022 | Page 2

On the other hand, there are also factors that hinder the growth of Head & Neck Cancer Market including patent expiry
of current drugs, side effects post treatment, difficulty in diagnosis, and the high expenditure on the cancer therapy.
The global Head & Neck Cancer Market has been classified on the basis of type, stages, diagnostic method, treatment,
end–user, and geography. On the basis of type, the global Head & Neck Cancer Market size constitutes nasal cavity
and paranasal sinus cancer, nasopharyngeal cancer, laryngeal and hypo pharyngeal cancer, oral and oropharyngeal
cancer, and salivary gland cancer. During the forecast period oral cancer is expected to account for the largest share
in the global Head & Neck Cancer Market.
On the basis of Head & Neck Cancer stage, the global Head & Neck Cancer Market size comprises stage 0, stage I, stage
II, stage III, and stage IV. Cancer staging is an important aspect as it guides the doctors to categorize the approach of
treatment and also to conclude the spread of cancer.
On the basis of diagnostic method, the global Head & Neck Cancer Market size constitutes bioscopy screening tests,
blood tests, dental diagnostic method, imaging diagnostic equipment, and endoscopy screening equipment. The
imaging diagnostic equipment sector can be further classified as MRI, X-rays, CT scan, ultrasound, and PET. On the
basis of treatment, the global Head & Neck Cancer Market size covers surgery, chemotherapy, radiation therapy,
external radiation therapy, internal radiation therapy, and targeted therapy. During the forecast period surgery is
estimated to dominate the treatment sector. Radiation therapy is followed by surgery owing to its utility in inhibition
and reappearance of cancer.
Get a Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/head-neck-cancer-treatment-market/request-sample
On the basis of end-user, the global Head & Neck Cancer Market size gives hospitals, specialty clinics, and ambulatory
surgical centres. The hospitals are anticipated to hold the largest share in the global Head & Neck Cancer Market. On
the basis of geography, the global Head & Neck Cancer Market size gives North America, Europe, Asia Pacific, and
Africa. In 2014, the North American market accounted for the largest market share of Head & Neck Cancer owing to
the increasing aging population subsequently increasing the frequency of chronic diseases associated with Head &
Neck Cancer. Some of the prominent players that fuel the growth of the global Head & Neck Cancer Market include
Siemens Healthcare, AdDent, Inc., Varian Medical Systems, Philips Healthcare, GE Healthcare, and Identafi.
Market Segment:
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million
USD), market share and growth rate of Head and Neck Cancer Treatment in these regions, from 2012 to 2022
(forecast), covering
• North America
• Europe
• China